Jordi Vila Selected Research

avibactam

1/2021

Emergence of Resistance to Novel Cephalosporin-β-Lactamase Inhibitor Combinations through the Modification of the Pseudomonas aeruginosa MexCD-OprJ Efflux Pump.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jordi Vila Research Topics

Disease

44	Infections 07/2022 - 04/2002
11	Pneumonia (Pneumonitis) 01/2021 - 04/2006
10	Diarrhea 01/2019 - 10/2004
8	COVID-19 06/2022 - 01/2021
8	Sepsis (Septicemia) 11/2019 - 03/2011
5	Cross Infection (Nosocomial Infection) 01/2020 - 09/2009
5	Pyelonephritis 08/2015 - 10/2002
4	Fibrosis (Cirrhosis) 01/2022 - 01/2002
4	Bacteremia 09/2020 - 03/2011
4	Urinary Tract Infections (Urinary Tract Infection) 08/2015 - 12/2005
4	Cystitis 08/2015 - 10/2002
4	Peritonitis 03/2012 - 01/2002
3	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022 - 08/2012
3	Healthcare-Associated Pneumonia 01/2021 - 01/2017
3	Ventilator-Associated Pneumonia 01/2021 - 09/2014
3	Human Influenza (Influenza) 01/2021 - 02/2015
3	Communicable Diseases (Infectious Diseases) 04/2020 - 01/2004
3	Critical Illness (Critically Ill) 01/2016 - 03/2009
3	Bacterial Infections (Bacterial Infection) 08/2015 - 01/2002
3	Prostatitis 01/2005 - 01/2002
2	Encephalitis (Encephalitis, Rasmussen) 10/2021 - 04/2020
2	Meningitis 10/2021 - 04/2020
2	Central Nervous System Infections (Central Nervous System Infection) 10/2021 - 04/2020
2	Chronic Obstructive Pulmonary Disease (COPD) 11/2019 - 05/2016
2	Inflammation (Inflammations) 11/2019 - 01/2014
2	Impetigo (Impetigo Contagiosa) 01/2019 - 01/2018
2	Pneumococcal Infections 01/2018 - 05/2016
2	Body Weight (Weight, Body) 01/2017 - 05/2013
2	Septic Shock (Toxic Shock Syndrome) 01/2017 - 04/2014
2	Melioidosis 04/2015 - 01/2015
1	Lung Injury 01/2018
1	Soft Tissue Infections 01/2018

Drug/Important Bio-Agent (IBA)

27	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 06/2002
8	Carbapenems (Carbapenem Antibiotics)IBA 09/2020 - 02/2009
8	Anti-Infective Agents (Microbicides)IBA 04/2020 - 01/2004
8	QuinolonesIBA 01/2019 - 01/2002
6	Colistin (Coly-Mycin)FDA Link 03/2020 - 02/2009
6	Virulence Factors (Pathogenicity Factors)IBA 08/2015 - 12/2002
5	FluoroquinolonesIBA 08/2015 - 07/2003
4	Pharmaceutical PreparationsIBA 01/2021 - 11/2012
4	Biomarkers (Surrogate Marker)IBA 11/2019 - 06/2014
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 09/2014
4	Norfloxacin FDA Link 03/2012 - 01/2002
3	ozenoxacinIBA 01/2019 - 03/2014
3	Third Generation CephalosporinsIBA 01/2019 - 01/2012
3	VaccinesIBA 05/2016 - 01/2015
2	Antiviral Agents (Antivirals)IBA 06/2022 - 01/2021
2	Complement System Proteins (Complement)IBA 01/2022 - 08/2015
2	C-Reactive ProteinIBA 01/2022 - 11/2019
2	tazobactam drug combination ceftolozaneIBA 01/2021 - 01/2021
2	ProcalcitoninIBA 11/2019 - 01/2017
2	EndotoxinsIBA 01/2017 - 04/2014
2	Lipopolysaccharide ReceptorsIBA 02/2016 - 01/2014
2	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2016 - 01/2002
2	DNA (Deoxyribonucleic Acid)IBA 08/2015 - 04/2006
2	Nucleic AcidsIBA 02/2015 - 08/2009
2	EnzymesIBA 10/2014 - 10/2009
2	AlbuminsIBA 09/2014 - 01/2004
2	Cephalosporins (Cephalosporin Antibiotics)IBA 08/2014 - 03/2009
2	Imipenem FDA Link 07/2014 - 04/2009
2	Vancomycin FDA LinkGeneric 08/2012 - 07/2012
2	Linezolid (Zyvox)FDA Link 08/2012 - 07/2012
2	Nalidixic Acid FDA Link 03/2010 - 10/2002
2	beta-LactamsIBA 05/2006 - 06/2003
2	GlycopeptidesIBA 06/2003 - 04/2003
2	Hemolysin Proteins (Hemolysins)IBA 12/2002 - 10/2002
2	aerobactinIBA 12/2002 - 10/2002
1	CefiderocolIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	ClinitestIBA 01/2022
1	AntigensIBA 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	remdesivirIBA 11/2021
1	avibactamIBA 01/2021
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 01/2021
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2021
1	Meropenem (Merrem)FDA LinkGeneric 01/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2019
1	CeramidesIBA 11/2019
1	LipidsIBA 11/2019
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 11/2019
1	SphingomyelinsIBA 11/2019
1	AcidsIBA 11/2019
1	LactamsIBA 01/2019
1	CephamycinsIBA 01/2019
1	Lipocalin-2IBA 01/2019
1	N-(3-oxododecanoyl)homoserine lactoneIBA 01/2018
1	Lysergic Acid Diethylamide (LSD)IBA 01/2018
1	Loperamide (Imodium)FDA LinkGeneric 04/2017
1	bismuth subsalicylate (Pepto-bismol)FDA LinkGeneric 04/2017

Therapy/Procedure

22	Therapeutics 06/2022 - 01/2002
3	Critical Care (Surgical Intensive Care) 07/2022 - 12/2015
2	Length of Stay 01/2021 - 01/2016
2	Catheters 01/2016 - 03/2011
2	Parenteral Nutrition 05/2015 - 04/2006
2	Prostheses and Implants (Prosthesis) 10/2011 - 01/2008
1	Personal Protective Equipment 12/2021
1	Aftercare (After-Treatment) 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Antibiotic Prophylaxis 04/2017